Pot stocks have been relatively flimsy this week since a report from Statistics Canada showed that cannabis consumption hasn’t changed much since the legal pot market was rolled out.
Why the U.S. can refocus its regulatory approach to pharmaceuticals, adapted from the one used in Europe, to better connect the value prescription drugs provide and their price.